U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H26N2O2.ClH
Molecular Weight 362.894
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HYDROQUINIDINE HYDROCHLORIDE

SMILES

Cl.[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2CC)[C@@H](O)C3=CC=NC4=CC=C(OC)C=C34

InChI

InChIKey=MULXTQKDWYBJMO-VJAUXQICSA-N
InChI=1S/C20H26N2O2.ClH/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18;/h4-6,8,11,13-14,19-20,23H,3,7,9-10,12H2,1-2H3;1H/t13-,14-,19+,20-;/m0./s1

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C20H26N2O2
Molecular Weight 326.4326
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/24068450 http://www.ajtmh.org/content/s1-12/6/473.full.pdf

Hydroquinidine is a pharmaceutical agent that acts as a class I antiarrhythmic agent (Ia) in the heart. Hydroquinidine is a d-rotatory alkaloid derived from cinchiona bark. It is closely related to quinidine, differing from the latter alkaloid only in containing two more atoms of hydrogen in the molecule. The drug causes increased action potential duration, as well as a prolonged QT interval. It is not approved by FDA, but marketed in Spain, France, Italy and Pakistan under the brand names Lentoquine, Sérécor LP, Idrochinidina Lirca and Austacute, respectively. Like all other class I antiarrhythmic agents, Hydroquinidine primarily works by blocking the fast inward sodium current (INa). Hydroquinidine is also used for the treatment of Malaria.

Approval Year

PubMed

PubMed

TitleDatePubMed
[Hepatitis caused by quinidine. Study of a case and review of the literature].
1986 Mar
Safety and effectiveness of oral quinidine in cardioversion of persistent atrial fibrillation.
2001 Dec
[Adverse drug reactions in three older patients, even without changes in medication].
2003 Mar 29
The relationship of physico-chemical properties and structure to the differential antiplasmodial activity of the cinchona alkaloids.
2003 Sep 1
The molecular phenotype of endocapillary proliferation: novel therapeutic targets for IgA nephropathy.
2014
Patents

Sample Use Guides

500 mg/12 h mg daily
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: Recordings were made from acutely dissociated melanotrophs, obtained following the enzymatic treatment and mechanical disruption of the neuro-intermediate lobe of the pituitary gland of the adult male rat
Halfmaximal inhibition of IK(f) at o mV occurred with 23 + 7.8uM hydroquinidine
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:02:46 GMT 2023
Edited
by admin
on Fri Dec 15 18:02:46 GMT 2023
Record UNII
6BR4G8VAHM
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
HYDROQUINIDINE HYDROCHLORIDE
MART.   MI   WHO-DD  
Common Name English
Hydroquinidine hydrochloride [WHO-DD]
Common Name English
HYDROQUINIDINE HCL
Common Name English
SERECOR
Brand Name English
(9S)-10,11-DIHYDRO-6'-METHOXYCINCHONAN-9-OL HYDROCHLORIDE
Common Name English
HYDROCONCHININE HYDROCHLORIDE
Common Name English
HYDROQUINIDINE HYDROCHLORIDE [MI]
Common Name English
HYDROQUINIDINE HYDROCHLORIDE [MART.]
Common Name English
Code System Code Type Description
PUBCHEM
16211709
Created by admin on Fri Dec 15 18:02:46 GMT 2023 , Edited by admin on Fri Dec 15 18:02:46 GMT 2023
PRIMARY
ECHA (EC/EINECS)
216-024-1
Created by admin on Fri Dec 15 18:02:46 GMT 2023 , Edited by admin on Fri Dec 15 18:02:46 GMT 2023
PRIMARY
FDA UNII
6BR4G8VAHM
Created by admin on Fri Dec 15 18:02:46 GMT 2023 , Edited by admin on Fri Dec 15 18:02:46 GMT 2023
PRIMARY
CAS
1476-98-8
Created by admin on Fri Dec 15 18:02:46 GMT 2023 , Edited by admin on Fri Dec 15 18:02:46 GMT 2023
PRIMARY
MESH
C014486
Created by admin on Fri Dec 15 18:02:46 GMT 2023 , Edited by admin on Fri Dec 15 18:02:46 GMT 2023
PRIMARY
EVMPD
SUB14137MIG
Created by admin on Fri Dec 15 18:02:46 GMT 2023 , Edited by admin on Fri Dec 15 18:02:46 GMT 2023
PRIMARY
EPA CompTox
DTXSID00933162
Created by admin on Fri Dec 15 18:02:46 GMT 2023 , Edited by admin on Fri Dec 15 18:02:46 GMT 2023
PRIMARY
SMS_ID
100000077619
Created by admin on Fri Dec 15 18:02:46 GMT 2023 , Edited by admin on Fri Dec 15 18:02:46 GMT 2023
PRIMARY
RXCUI
236160
Created by admin on Fri Dec 15 18:02:46 GMT 2023 , Edited by admin on Fri Dec 15 18:02:46 GMT 2023
PRIMARY RxNorm
MERCK INDEX
m6113
Created by admin on Fri Dec 15 18:02:46 GMT 2023 , Edited by admin on Fri Dec 15 18:02:46 GMT 2023
PRIMARY Merck Index
Related Record Type Details
PARENT -> SALT/SOLVATE